Journal of Clinical Virology
Volume 44, Issue 2 , Pages 149-151, February 2009

The effect of controlled therapy interruption in chronic HCV infection: Enhanced host immune response? A hypothesis

  • Gerond Lake-Bakaar

      Affiliations

    • Corresponding Author InformationCurrent address: Liver Center, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street, Suite 7A-055, USA. Tel.: +1 617 632 9838; fax: +1 617 632 9804.

Division of Gastroenterology-Hepatology and Department of Medicine, Weill Cornell University Medical College, New York, NY 10021, USA

Received 30 August 2008; received in revised form 25 November 2008; accepted 26 November 2008. published online 21 January 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1386-6532(08)00409-5

doi:10.1016/j.jcv.2008.11.017

Journal of Clinical Virology
Volume 44, Issue 2 , Pages 149-151, February 2009

Article Tools

* Image Usage & Resolution